cello health group limited
cello health group limited Company Information
Company Number
03636143
Next Accounts
Sep 2025
Shareholders
cello health limited
Group Structure
View All
Industry
Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
Registered Address
great suffolk yard, 127-131 great suffolk street, london, SE1 1PP
Website
www.cellogroup.co.ukcello health group limited Estimated Valuation
Pomanda estimates the enterprise value of CELLO HEALTH GROUP LIMITED at £0 based on a Turnover of £0 and 1.05x industry multiple (adjusted for size and gross margin).
cello health group limited Estimated Valuation
Pomanda estimates the enterprise value of CELLO HEALTH GROUP LIMITED at £0 based on an EBITDA of £0 and a 4.38x industry multiple (adjusted for size and gross margin).
cello health group limited Estimated Valuation
Pomanda estimates the enterprise value of CELLO HEALTH GROUP LIMITED at £3.8m based on Net Assets of £2.9m and 1.31x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Cello Health Group Limited Overview
Cello Health Group Limited is a live company located in london, SE1 1PP with a Companies House number of 03636143. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in September 1998, it's largest shareholder is cello health limited with a 100% stake. Cello Health Group Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Cello Health Group Limited Health Check
Pomanda's financial health check has awarded Cello Health Group Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 3 areas for improvement. Company Health Check FAQs
1 Strong
0 Regular
3 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Cello Health Group Limited
- - Industry AVG
Growth
3 year (CAGR) sales growth of -100%, show it is growing at a slower rate (10.5%)
- - Cello Health Group Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Cello Health Group Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Cello Health Group Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (104)
- Cello Health Group Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Cello Health Group Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Cello Health Group Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Cello Health Group Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Cello Health Group Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Cello Health Group Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 7 weeks, this is less cash available to meet short term requirements (14 weeks)
- - Cello Health Group Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 17%, this is a lower level of debt than the average (69.6%)
- - Cello Health Group Limited
- - Industry AVG
CELLO HEALTH GROUP LIMITED financials
Cello Health Group Limited's latest turnover from December 2023 is 0 and the company has net assets of £2.9 million. According to their latest financial statements, we estimate that Cello Health Group Limited has 1 employee and maintains cash reserves of £84.1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 39,983 | 543,244 | 488,373 | 526,295 | 601,497 | 498,442 | 487,298 | 475,423 | 405,444 | 652,752 | 418,429 | 478,548 | |||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | 601,497 | 498,442 | 487,298 | 652,752 | 418,429 | 478,548 | |||||||||
| Admin Expenses | 587,921 | 478,995 | 400,815 | 648,495 | 1,117,395 | 795,570 | |||||||||
| Operating Profit | -30 | -287 | 39,983 | -127,856 | 280,180 | 37,370 | 13,576 | 19,447 | 86,483 | -62,267 | 24,438 | 4,257 | -698,966 | -317,022 | |
| Interest Payable | 17,058 | 20,513 | 15,337 | 12,000 | |||||||||||
| Interest Receivable | 42,819 | 42,851 | 32,751 | 14,466 | 12,756 | 10,525 | 9,914 | 10,751 | 2,313 | 137 | |||||
| Pre-Tax Profit | 42,819 | 42,821 | 32,464 | 54,449 | -115,100 | 290,705 | 47,284 | 24,327 | 21,760 | 86,620 | 1,120,675 | 403,925 | -11,080 | -539,501 | 4,414,189 |
| Tax | -9,090 | -7,156 | -5,462 | -88,337 | -10,352 | -5,641 | -12,802 | -1,518 | 11,278 | -38,742 | 19,872 | -10,045 | -29,879 | -4,140 | 52,596 |
| Profit After Tax | 33,729 | 35,665 | 27,002 | -33,888 | -125,452 | 285,064 | 34,482 | 22,809 | 33,038 | 47,878 | 1,140,547 | 393,880 | -40,959 | -543,641 | 4,466,785 |
| Dividends Paid | 500,000 | 3,200,000 | |||||||||||||
| Retained Profit | 33,729 | 35,665 | 27,002 | -33,888 | -125,452 | -214,936 | 34,482 | 22,809 | 33,038 | 47,878 | 1,140,547 | 393,880 | -40,959 | -543,641 | 1,266,785 |
| Employee Costs | 439,936 | 441,483 | 270,277 | 235,781 | 249,845 | 210,728 | 204,054 | 210,419 | 310,367 | 389,244 | 509,028 | ||||
| Number Of Employees | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 4 | |||
| EBITDA* | -30 | -287 | 40,665 | -127,241 | 280,770 | 37,775 | 13,700 | 20,005 | 86,483 | -62,267 | 24,438 | 4,257 | -698,966 | -317,022 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 796 | 1,478 | 792 | 1,382 | 297 | 142 | 700 | 959 | 1,439 | ||||||
| Intangible Assets | |||||||||||||||
| Investments & Other | 2,084,513 | 2,084,513 | 2,084,513 | 2,084,513 | 2,084,513 | 2,255,978 | 2,592,134 | 2,592,134 | 2,592,134 | 2,592,134 | 2,592,134 | 2,592,134 | 2,592,134 | 2,592,134 | 2,354,267 |
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 2,084,513 | 2,084,513 | 2,084,513 | 2,085,309 | 2,085,991 | 2,256,770 | 2,593,516 | 2,592,431 | 2,592,276 | 2,592,834 | 2,593,093 | 2,593,573 | 2,592,134 | 2,592,134 | 2,354,267 |
| Stock & work in progress | |||||||||||||||
| Trade Debtors | |||||||||||||||
| Group Debtors | 1,345,905 | 1,352,205 | 1,333,270 | 959,389 | 1,260,303 | 333,434 | 921,957 | 1,057,088 | 889,968 | 514,453 | 251,916 | 685,019 | 414,780 | 230,953 | 608,647 |
| Misc Debtors | 175 | 174 | 175 | 56 | 82,401 | 62,696 | 72,518 | 49,923 | 37,402 | 36,719 | 23,987 | 4,984 | 11,596 | 31,477 | 55,738 |
| Cash | 84,134 | 46,417 | 24,019 | 320,261 | 47,931 | 508,755 | 195,020 | 84,310 | 442,898 | 525,487 | 2 | ||||
| misc current assets | |||||||||||||||
| total current assets | 1,430,214 | 1,398,796 | 1,357,464 | 1,279,706 | 1,390,635 | 904,885 | 1,189,495 | 1,107,011 | 1,011,680 | 994,070 | 801,390 | 690,005 | 426,376 | 262,430 | 664,385 |
| total assets | 3,514,727 | 3,483,309 | 3,441,977 | 3,365,015 | 3,476,626 | 3,161,655 | 3,783,011 | 3,699,442 | 3,603,956 | 3,586,904 | 3,394,483 | 3,283,578 | 3,018,510 | 2,854,564 | 3,018,652 |
| Bank overdraft | 4,017 | 488,836 | 362,613 | 75,120 | 22,121 | ||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 214 | 103 | 1,592 | 1,678 | 315 | 1,470 | 905 | 3,220 | 5,848 | 10,356 | 8,030 | ||||
| Group/Directors Accounts | 586,081 | 590,327 | 586,681 | 525,138 | 590,412 | 122,942 | 501,784 | 520,844 | 516,791 | 517,355 | 301,935 | 957,645 | 1,212,676 | 1,313,067 | 1,230,595 |
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 10,071 | 8,136 | 6,115 | 17,698 | 29,933 | 89,774 | 131,174 | 102,744 | 66,886 | 88,586 | 195,935 | 87,079 | 91,320 | 74,840 | 86,241 |
| total current liabilities | 596,152 | 598,463 | 592,796 | 542,836 | 620,559 | 212,819 | 634,550 | 629,283 | 583,992 | 607,411 | 498,775 | 1,536,780 | 1,672,457 | 1,473,383 | 1,346,987 |
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | |||||||||||||||
| total liabilities | 596,152 | 598,463 | 592,796 | 542,836 | 620,559 | 212,819 | 634,550 | 629,283 | 583,992 | 607,411 | 498,775 | 1,536,780 | 1,672,457 | 1,473,383 | 1,346,987 |
| net assets | 2,918,575 | 2,884,846 | 2,849,181 | 2,822,179 | 2,856,067 | 2,948,836 | 3,148,461 | 3,070,159 | 3,019,964 | 2,979,493 | 2,895,708 | 1,746,798 | 1,346,053 | 1,381,181 | 1,671,665 |
| total shareholders funds | 2,918,575 | 2,884,846 | 2,849,181 | 2,822,179 | 2,856,067 | 2,948,836 | 3,148,461 | 3,070,159 | 3,019,964 | 2,979,493 | 2,895,708 | 1,746,798 | 1,346,053 | 1,381,181 | 1,671,665 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | -30 | -287 | 39,983 | -127,856 | 280,180 | 37,370 | 13,576 | 19,447 | 86,483 | -62,267 | 24,438 | 4,257 | -698,966 | -317,022 | |
| Depreciation | 682 | 615 | 590 | 405 | 124 | 558 | |||||||||
| Amortisation | |||||||||||||||
| Tax | -9,090 | -7,156 | -5,462 | -88,337 | -10,352 | -5,641 | -12,802 | -1,518 | 11,278 | -38,742 | 19,872 | -10,045 | -29,879 | -4,140 | 52,596 |
| Stock | |||||||||||||||
| Debtors | -6,299 | 18,934 | 374,000 | -383,259 | 946,574 | -598,345 | -112,536 | 179,641 | 376,198 | 275,269 | -414,100 | 263,627 | 163,946 | -401,955 | 664,385 |
| Creditors | -214 | 111 | -1,489 | -86 | 1,363 | -1,155 | 565 | -2,315 | -2,628 | -4,508 | 2,326 | 8,030 | |||
| Accruals and Deferred Income | 1,935 | 2,021 | -11,583 | -12,235 | -59,841 | -41,400 | 28,430 | 35,858 | -21,700 | -107,349 | 108,856 | -4,241 | 16,480 | -11,401 | 86,241 |
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | -856 | -24,099 | -391,332 | 323,138 | -1,143,897 | 830,585 | 165,853 | -130,238 | -367,770 | -334,312 | 478,246 | -256,103 | -177,596 | -310,226 | -834,540 |
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | -171,465 | -336,156 | 237,867 | 2,354,267 | |||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | -4,246 | 3,646 | 61,543 | -65,274 | 467,470 | -378,842 | -19,060 | 4,053 | -564 | 215,420 | -655,710 | -255,031 | -100,391 | 82,472 | 1,230,595 |
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | 42,819 | 42,851 | 32,751 | 14,466 | 12,756 | 10,525 | 9,914 | 10,751 | 2,313 | 137 | -17,058 | -20,513 | -15,337 | -12,000 | |
| cash flow from financing | 38,573 | 46,497 | 94,294 | -50,808 | 512,909 | -353,006 | 34,674 | 42,190 | 9,182 | 251,464 | -664,405 | -268,679 | -109,897 | 323,629 | 1,635,475 |
| cash and cash equivalents | |||||||||||||||
| cash | 37,717 | 22,398 | -296,242 | 272,330 | -460,824 | 313,735 | 195,020 | -84,310 | -358,588 | -82,589 | 525,485 | 2 | |||
| overdraft | -4,017 | 4,017 | -488,836 | 126,223 | 287,493 | 52,999 | 22,121 | ||||||||
| change in cash | 37,717 | 22,398 | -296,242 | 272,330 | -460,824 | 313,735 | 199,037 | -88,327 | -358,588 | -82,589 | 1,014,321 | -126,221 | -287,493 | -52,999 | -22,121 |
cello health group limited Credit Report and Business Information
Cello Health Group Limited Competitor Analysis
Perform a competitor analysis for cello health group limited by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other mature companies, companies in SE1 area or any other competitors across 12 key performance metrics.
cello health group limited Ownership
CELLO HEALTH GROUP LIMITED group structure
Cello Health Group Limited has 3 subsidiary companies.
Ultimate parent company
ARSENAL CAPITAL PARTNERS V LP
#0030621
2 parents
CELLO HEALTH GROUP LIMITED
03636143
3 subsidiaries
cello health group limited directors
Cello Health Group Limited currently has 2 directors. The longest serving directors include Mr Jon Williams (Apr 2023) and M Michael Madden (Dec 2023).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Jon Williams | England | 49 years | Apr 2023 | - | Director |
| M Michael Madden | United Kingdom | 46 years | Dec 2023 | - | Director |
P&L
December 2023turnover
0
0%
operating profit
0
-100%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
2.9m
+0.01%
total assets
3.5m
+0.01%
cash
84.1k
+0.81%
net assets
Total assets minus all liabilities
cello health group limited company details
company number
03636143
Type
Private limited with Share Capital
industry
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
incorporation date
September 1998
age
27
incorporated
UK
ultimate parent company
accounts
Audit Exemption Subsidiary
last accounts submitted
December 2023
previous names
cello signal group limited (February 2020)
tangible group limited (June 2014)
See moreaccountant
-
auditor
-
address
great suffolk yard, 127-131 great suffolk street, london, SE1 1PP
Bank
THE ROYAL BANK OF SCOTLAND PLC
Legal Advisor
-
cello health group limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to cello health group limited. Currently there are 2 open charges and 1 have been satisfied in the past.
cello health group limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CELLO HEALTH GROUP LIMITED. This can take several minutes, an email will notify you when this has completed.
cello health group limited Companies House Filings - See Documents
| date | description | view/download |
|---|
